Efficacy of LY333328 against Experimental Methicillin-Resistant Staphylococcus aureus Endocarditis
The in vivo efficacy of LY333328, a new glycopeptide antibiotic, was compared with that of vancomycin by using the rabbit model of left-sided methicillin-resistant Staphylococcus aureus endocarditis. Animals received LY333328 or vancomycin (25 mg/kg of body weight every 24 or 8 h, respectively) for...
Kaydedildi:
| Yayımlandı: | Antimicrob Agents Chemother |
|---|---|
| Asıl Yazarlar: | , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
American Society for Microbiology (ASM)
1998
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC105587/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/9559828/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.42.4.981 |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|